Literature DB >> 15346569

New risk information on IBS drug Zelnorm.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15346569

Source DB:  PubMed          Journal:  FDA Consum        ISSN： 0362-1332


× No keyword cloud information.
  1 in total

1.  Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study.

Authors:  Revital Kariv; Elisa Tiomny; Roman Grenshpon; Roy Dekel; Galit Waisman; Yehuda Ringel; Zamir Halpern
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.